Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash Flows from operating activities:
Net loss	$ (1,371,945)	$ 13,957
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	20,349	19,381
Net losses realized on the sale of securities and net credit losses recognized in operations	909,121	35,898
Unrealized losses (gains) on equity securities	21,790	(96,321)
Change in fair value of embedded derivative	118,762	(79,929)
(Accretion) amortization of investment securities, net	(102,099)	(112,213)
Deferred acquisition costs capitalized	(355,696)	(124,726)
Deferred acquisition costs amortized	307,262	362,810
Value of business acquired amortized	23,105	23,105
Change in deferred tax assets	(256,382)	0
Interest credited on deposit type contracts	519,097	454,517
Investment income due and accrued	(64,258)	(159,459)
Reinsurance related assets	(467,236)	417,581
Other assets	6,561	41,104
Policyowner benefit reserves	1,600,924	1,145,795
Dividend accumulation	(1,240)	919
Advance premiums	(11,090)	19,340
Other liabilities	477,961	144,098
Accounts payable and accrued expenses	878,172	279,586
Net cash provided by operating activities	2,253,158	2,385,443
Cash Flows from investing activities:
Purchase of fixed income investments	(1,863,263)	(2,507,233)
Purchase of equity investments	(461,430)	(101,406)
Purchase of mortgage investments	(132,785)	(252,642)
Purchase of other invested assets	0	(26,320)
Proceeds from fixed income sales and repayments	3,148,409	2,277,763
Proceeds from equity sales	3,000	96,428
Proceeds from mortgage repayments	561,216	1,200,925
Proceeds from other invested assets	0	5,440
Increase in policy loans	(768)	(623)
Purchase of property, equipment and software	0	(11,127)
Net cash provided by investing activities	1,254,379	681,205
Cash Flows from financing activities:
Receipts on deposit-type contracts	1,311,824	2,119,530
Withdrawals on deposit-type contracts	(5,011,589)	(3,024,646)
Paid in capital	9,886
Net cash (used in) financing activities	(3,689,879)	(905,116)
Net (decrease) increase in cash and cash equivalents	(182,342)	2,161,532
Cash and Cash Equivalents:
Beginning	6,903,783	8,982,138
Ending	$ 6,721,441	$ 11,143,670